AFCG earnings analysis
What we found in AFCG's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The extracted 10-Q text does not include the income statement, balance sheet, cash flow statement, segment results, or current-quarter EPS and revenue, preventing a complete assessment of operating trends. The principal negative is the $78.8 million Justice Cannabis loan exposure, which matured unpaid and remains subject to enforcement actions and multiple lawsuits. Continued share repurchases of 839,406 shares and a mixed floating-/fixed-rate portfolio are positives, but interest-rate sensitivity and substantial litigation uncertainty support a bearish filing-level assessment.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Share Repurchases Continued
- The company repurchased 839,406 shares during the quarter at an average price of $3.29 per share, leaving $2,236,941 available under the $5.0 million repurchase authorization.
- Mixed-Rate Financing Structure
- The June 26, 2026 credit agreement amendment supports financing flexibility; the filing states that borrowings under the Revolving Credit Facility bear interest at a floating rate, while the TCGSL Credit Facility and 2027 Senior Notes bear fixed rates.
- Portfolio Rate Diversification
- Management reported that 55.4% of performing debt investments were floating-rate and 44.6% were fixed-rate on a fair-value basis as of June 30, 2026, providing partial protection against changes in market rates.
- Interest-Rate Sensitivity Quantified
- A 100-basis-point increase in base rates was estimated to reduce annual net investment income by $402,777, while a 100-basis-point decrease was estimated to reduce it by $269,535.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- $78.8M Justice Cannabis Exposure
- Approximately $78.8 million of principal remains outstanding on the Justice Cannabis Company credit facility after it matured on May 1, 2026 without repayment. Collateral dispositions were rescheduled for September 24, 2026 and October 6, 2026, and the filing states that litigation outcomes remain uncertain.
- Extensive Litigation and Enforcement Risk
- The company disclosed multiple ongoing legal actions involving Justice Cannabis-related borrowers, including a preliminary-injunction hearing scheduled for September 15, 2026 and a counterclaim alleging that the credit agreement and security interests are unenforceable.
- Interest-Rate Margin Pressure
- A 300-basis-point increase in base rates was estimated to reduce annual net investment income by $2,750, while the filing states that rising borrowing costs could reduce net income or result in a net loss. As of June 30, 2026, 55.4% of performing debt investments were floating-rate versus 44.6% fixed-rate.
- No Formal Risk-Factor Changes
- The filing states that there were no material changes to the risk factors disclosed in the 2025 Form 10-K and subsequent 10-Q filings, so no new formal risk-factor changes were identified.
What they said about what is next.
No quantitative revenue or EPS outlook was provided in the extracted 10-Q text; the filing does not provide explicit guidance ranges.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 7, 2026
- Advanced Flower Capital Inc. reported a strong performance in Q1 2026, achieving total investment income of $9.8 million, up 16% from $8.5 million in Q1 2025. The transition to a business development company has brought…
- 10-K · March 4, 2026
- Advanced Flower Capital completed a conversion from a REIT to a BDC effective January 1, 2026, expanding its investment mandate beyond real-estate‑backed cannabis loans. As of February 25, 2026 the company reports a…
- 10-Q · November 12, 2025
- AFC reported a weak quarter driven by credit deterioration and mark-to-market losses: interest income of $8,162,075 and net loss of $(12,490,506) for the three months ended September 30, 2025 (compared with net income…
- 10-K · March 13, 2025
- Advanced Flower Capital positions itself as an institutional lender to state-law-compliant cannabis operators, focusing on senior secured loans typically backed by real estate, equipment, cash flows and license value.…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing AFCG makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever